Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen (Q42487505)

1 November 2017

title

Unilateral 6-hydroxydopamine lesions of nigrostriatal dopaminergic neurons increased CB1 receptor mRNA levels in the caudate-putamen (English)

1 reference

1 November 2017

0 references

1 reference

Romero J

1

1 reference

1 November 2017

Berrendero F

2

1 reference

1 November 2017

Pérez-Rosado A

3

1 reference

1 November 2017

Manzanares J

4

1 reference

1 November 2017

Rojo A

5

1 reference

1 November 2017

Fernández-Ruiz JJ

6

1 reference

1 November 2017

de Yebenes JG

7

1 reference

1 November 2017

Ramos JA

8

1 reference

1 November 2017

language of work or name

English

0 references

publication date

1 January 2000

1 reference

1 November 2017

1 reference

1 November 2017

volume

66

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

485-494

1 reference

Tetrahydrocannabinol potentiates reserpine-induced hypokinesia

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Motor disturbances induced by an acute dose of delta 9-tetrahydrocannabinol: possible involvement of nigrostriatal dopaminergic alterations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Downregulation of rat brain cannabinoid binding sites after chronic delta 9-tetrahydrocannabinol treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

delta 9-Tetrahydrocannabinol and anandamide enhance the ability of muscimol to induce catalepsy in the globus pallidus of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

The endogenous cannabinoid receptor ligand, anandamide, inhibits the motor behavior: role of nigrostriatal dopaminergic neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Time-course of the effects of anandamide, the putative endogenous cannabinoid receptor ligand, on extrapyramidal function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

The activation of cannabinoid receptors in striatonigral GABAergic neurons inhibited GABA uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Modulation of GABAergic transmission in the globus pallidus by the synthetic cannabinoid WIN 55,212-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Activation of the cannabinoid receptor by delta 9-tetrahydrocannabinol reduces gamma-aminobutyric acid uptake in the globus pallidus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Presynaptic inhibition of GABAergic inputs to rat substantia nigra pars reticulata neurones by a cannabinoid agonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Distribution of neuronal cannabinoid receptor in the adult rat brain: a comparative receptor binding radioautography and in situ hybridization histochemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Role of the subthalamic nucleus in cannabinoid actions in the substantia nigra of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Ipsilateral turning behavior induced by unilateral microinjections of a cannabinoid into the rat subthalamic nucleus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Loss of cannabinoid receptors in the substantia nigra in Huntington's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Selective vulnerability in Huntington's disease: preferential loss of cannabinoid receptors in lateral globus pallidus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

The cannabinoid agonists WIN 55,212-2 and CP 55,940 attenuate rotational behavior induced by a dopamine D1 but not a D2 agonist in rats with unilateral lesions of the nigrostriatal pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Cannabinoid effects in basal ganglia in a rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Effects of intranigral cannabinoids on rotational behavior in rats: interactions with the dopaminergic system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Dopaminergic regulation of cannabinoid receptor mRNA levels in the rat caudate-putamen: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Dopaminergic neurons of the substantia nigra modulate preproenkephalin A gene expression in rat striatal neurons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Differences in G-protein activation by mu- and delta-opioid, and cannabinoid, receptors in rat striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Loss of cannabinoid receptor binding and messenger RNA levels and cannabinoid agonist-stimulated [35S]guanylyl-5'O-(thio)-triphosphate binding in the basal ganglia of aged rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Chronic CP-55,940 alters cannabinoid receptor mRNA in the rat brain: an in situ hybridization study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Perinatal delta9-tetrahydrocannabinol exposure did not alter dopamine transporter and tyrosine hydroxylase mRNA levels in midbrain dopaminergic neurons of adult male and female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Perinatal delta9-tetrahydrocannabinol exposure reduces proenkephalin gene expression in the caudate-putamen of adult female rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2899%2900618-9

10.1016/S0024-3205(99)00618-9

7 January 2021

Identifiers

DOI

1 reference

1 November 2017

1 reference